GlassScriptPhysician profile
Marissa Bailey
NPI 1467504860
$770.53
in general payments reported to CMS, 2019-2025
21 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $254 · 2024: $306 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $126.53 | 2023-2025 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Inspire Medical Systems, INC. | $85.76 | 2024 | Inspire |
| Hologic Sales and Service, LLC | $57.50 | 2023 | Aptima, Thinprep 2000 Processor |
| Exact Sciences Corporation | $52.40 | 2023-2025 | Cologuard Collection Kit |
| Aimmune Therapeutics, INC. | $50.96 | 2024-2025 | Zenpep |
| Edwards Lifesciences Corporation | $48.57 | 2024 | Sapien 3 Ultra Resilia |
| Ironshore Pharmaceuticals INC. | $45.08 | 2023-2024 | Jornay Pm |
| Ossur Americas, INC. | $38.78 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.35 | 2024 | |
| Corium, LLC | $32.50 | 2023 | Azstarys |
| Novo Nordisk INC | $24.79 | 2024 | Ozempic, Rybelsus |
| Amgen INC. | $23.48 | 2025 | Krystexxa |
| Boston Scientific Corporation | $20.65 | 2025 | Varithena Administration Pack |
| Cranial Technologies, INC | $19.14 | 2025 | Doc Band |
| Vertex Pharmaceuticals Incorporated | $19.07 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $18.89 | 2023 | Methylphenidate Hydrochloride |
| Kowa Pharmaceuticals America, INC. | $15.43 | 2023 | Livalo |
| Collegium Pharmaceutical, INC. | $14.76 | 2025 | Jornay Pm |
| Pfizer INC. | $14.57 | 2023 | |
| Vertical Pharmaceuticals, LLC | $14.47 | 2023 | Relexxii |
| Idorsia Pharmaceuticals US INC | $12.85 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marissa Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.